Position in ORGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$338,173
+$215,021 QoQ
Shares Held
139,166
+167.8% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 134 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HSBC HOLDINGS PLC holds $318,191,174 across 30 Drug Manufacturers - Specialty & Generic names. ORGO ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,839,811 | $132,208,811 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
127,125 | $68,880,136 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
785,524 | $26,613,551 | |
| 4 | VTRS |
Viatris Inc
|
1,518,578 | $24,115,016 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
632,408 | $21,925,584 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
115,990 | $19,548,952 | |
| 7 | LQDA |
Liquidia Corp
|
117,620 | $9,377,842 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
20,539 | $2,278,595 |
All Filings in ORGO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $338,173 | 139,166 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $123,152 | 51,963 | Shares | Defined | 2026-04-30 | |
| 2025-03-31 | $114,052 | 26,401 | Shares | Defined | 2025-05-14 | |
| 2023-12-31 | $108,863 | 26,617 | Shares | Defined | 2024-02-12 | |
| 2022-12-31 | $41,140 | 15,294 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $43,419 | 13,401 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $79,607 | 16,313 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $119,153 | 15,637 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||